Subscribe

Policy & Regulation Today - September 17, 2026

Daily policy & regulation roundup: 6 stories curated September 17, 2026. Lead: FDA, Sanofi, Gilead Weigh AI Readiness and Validation Risk at PDA/FDA Conference.

Policy & Regulation Today - September 17, 2026

The latest in policy & regulation: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: FDA, Sanofi, Gilead Weigh AI Readiness and Validation Risk at PDA/FDA Conference.

FDA, Sanofi, Gilead Weigh AI Readiness and Validation Risk at PDA/FDA Conference

BioPharm International2026-09-16

Digital Health Roundup: Oura Plans IPO, FDA’s Home Health, Digital Tools For Alzheimer’s Detection

insights.citeline.com2026-09-16

CMS: With Pledge, States Will Shift Medicaid Quality Measure Focus to Outcomes

HCI Innovation Group2026-09-16

As MA Denial Rates Rise, Hospitals Are Betting on Traditional Medicare Instead

As Medicare Advantage denial rates climb, health systems are dropping plans and steering patients back to traditional Medicare. Pearl Health CEO Michael Kopko thinks the original Medicare Advantage bargain has broken down — and that the model may never have been as efficient as policymakers assumed. The post As MA Denial Rates Rise, Hospitals Are Betting on Traditional Medicare Instead appear…

medcitynews.com2026-09-16

SEC and FDA Partner on Legal Compliance for Food and Drug Industries

Ogletree2026-09-16

CMS expands ACCESS pilot to boost use of digital health tech

MedTech Dive2026-09-16

Follow the full firehose on the HTC Wire, refreshed automatically every day.

Reach the people behind these stories. HealthTech Cube demand gen programs deliver qualified healthcare technology leads from $49.50 per lead - see packages or download the 2026 media kit.